Your browser doesn't support javascript.
loading
Solid lipid nanoparticles (SLNs), the potential novel vehicle for enhanced in vivo efficacy of hesperidin as an anti-inflammatory agent.
Shahraki, Omolbanin; Shayganpour, Mohaddeseh; Hashemzaei, Mahmoud; Daneshmand, Sara.
Affiliation
  • Shahraki O; Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran; Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Shayganpour M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.
  • Hashemzaei M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.
  • Daneshmand S; Department of Pharmaceutics, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran. Electronic address: s.daneshmand@zbmu.ac.ir.
Bioorg Chem ; 131: 106333, 2023 02.
Article in En | MEDLINE | ID: mdl-36587504
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Vehicles / Nanoparticles / Hesperidin / Anti-Inflammatory Agents Language: En Journal: Bioorg Chem Year: 2023 Document type: Article Affiliation country: Irán
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Vehicles / Nanoparticles / Hesperidin / Anti-Inflammatory Agents Language: En Journal: Bioorg Chem Year: 2023 Document type: Article Affiliation country: Irán